ST6GAL1
ST6GAL1 (ST6 beta-galactoside alpha-2,6-sialyltransferase 1, also known as CDw75 and SIAT1) is a Golgi sialyltransferase that transfers sialic acid from CMP-sialic acid to galactose-containing acceptor substrates. It contributes to cell-surface carbohydrate determinants and B lymphocyte differentiation antigens. Browse Assay Genie's current range of ST6GAL1 research reagents below, or read on for the biology behind the target.
ST6GAL1 catalyses the transfer of sialic acid from CMP-sialic acid to galactose-containing acceptor substrates. In B lymphocytes it generates neuraminidase-sensitive lymphocyte cell-surface differentiation antigens, including CDw75, HB-6 and CD76. It also sialylates complex-type N-glycans attached to the fragment crystallizable (Fc) region of IgG, a modification that confers anti-inflammatory effector functions. The enzyme preferentially monosialylates the alpha(1->3) mannose antenna of Fc glycoforms, and subsequent disialylation occurs at a much slower rate.
The ST6GAL1 gene encodes a member of glycosyltransferase family 29. The encoded protein is a type II membrane protein that is normally found in the Golgi, where it is located in the Golgi stack membrane, but it can be proteolytically processed to a soluble, secreted form. Alternative splicing of the gene results in multiple transcript variants. Researchers studying the ST6GAL1 protein therefore consider both its membrane-bound and soluble states.
HGNC places the gene in the sialyltransferase group, and earlier symbols and names include SIAT1 and sialyltransferase 1. Previous names also refer to beta-galactosamide and N-acetylgalactosaminide acceptors. NCBI Gene notes that the gene has been incorrectly referred to as CD75, although the enzyme is involved in generating the CD75 carbohydrate determinant alongside HB-6 and CD76. Mouse and rat both carry an orthologous St6gal1 gene.
As an alpha-2,6-sialyltransferase acting on galactose-containing substrates, ST6GAL1 is a model enzyme for studying how sialic acid is added to glycans in the Golgi.
ST6GAL1 generates the CDw75, HB-6 and CD76 cell-surface antigens in B lymphocytes, making it relevant to studies of lymphocyte differentiation markers.
Sialylation of complex N-glycans on IgG Fc by ST6GAL1 confers anti-inflammatory effector functions, which is central to research on antibody glycoforms.
ST6GAL1 resides in the Golgi but can be proteolytically processed to a soluble form, offering a system for studying glycosyltransferase trafficking and release.
ST6GAL1 transfers sialic acid from CMP-sialic acid to galactose-containing acceptor substrates. In B lymphocytes it forms differentiation antigens such as CDw75, HB-6 and CD76, and it sialylates complex-type N-glycans on the Fc region of IgG, conferring anti-inflammatory effector functions.
ST6GAL1 is also known as CDw75 and SIAT1, and as beta-galactoside alpha-2,6-sialyltransferase 1. Older names include sialyltransferase 1. NCBI notes the gene has been incorrectly called CD75, which is a carbohydrate determinant the enzyme helps generate. Alternative splicing produces multiple transcript variants.
Yes. Mouse and rat each have an orthologous gene named St6gal1. The human enzyme belongs to glycosyltransferase family 29 and is mainly found in the Golgi, though it can be processed to a soluble form. Check the datasheet of any product for its validated reactivity.
Other sialyltransferases and ST-prefixed targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P15907; product specifications from Assay Genie datasheets.